American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition, EV plant buildouts, and aerospace demand are pushing capital back into U.S.
Chemours NYSE: CC said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in its Thermal & Specialized Solutions and Titanium Technologies segments, while Advanced Performance Materials continued to recover from an outage at the company's Washington Works facility.
CC posted a wider Q1 loss as lower volumes hurt key segments, but pricing gains and upbeat Q2 sales guidance supported EBITDA.
The Chemours Company (CC) Q1 2026 Earnings Call Transcript
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The article analyzes the Canton Network and its CIP-0105 update, which incentivizes Super Validators to lock rewards, aligning interests with long-term network success. CIP-0105 could result in 20–32% of Canton Coin supply being locked over the long run, reducing circulating supply and disincentivizing opportunistic selling. Major financial institutions like Nasdaq, DTCC, and others serve as Super Validators, signaling strong institutional adoption and potential for network effects.
The Chemours Company (NYSE: CC - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 10,642 call options on the company. This is an increase of 182% compared to the typical volume of 3,771 call options. Chemours Stock Performance Shares of CC stock opened at $17.60 on Friday. Chemours has a
CC prices $700M of 7.875% senior notes due 2034, upsizing the deal to refinance 2027 and 2028 debt and reshape its debt profile.
Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.
CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.
While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Chemours (CC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of breakeven. This compares to earnings of $0.11 per share a year ago.